DexCom, Inc.

DXCM ·Healthcare, Medical Devices, United States
Financial Statements › Balance Sheet
Annual Quarterly

Balance Sheet

Line Item FY2017 FY2016 FY2015 FY2014 FY2013 FY2012 FY2011 FY2010
Assets
Cash & Equivalents $441.5M $94.5M $86.1M $71.8M $43.2M $8.1M $2.6M $4.9M
Accounts Receivable $134.3M $101.7M $74.1M $42.4M — — — —
Inventory $45.2M $45.4M $35.2M $16.0M $9.0M $7.4M $8.2M $8.1M
Total Current Assets $744.7M $280.0M $231.3M $145.9M $93.1M $77.6M $104.5M $65.4M
Property, Plant & Equipment $145.6M $109.4M $54.7M $31.2M $20.7M $18.9M $15.0M $10.8M
Goodwill $12.1M $11.3M $3.7M $3.2M $3.2M $3.2M $0 —
Intangible Assets (Excl. Goodwill) — $200.0K $2.2M $2.7M $3.6M $4.2M $0 —
Total Assets $904.1M $402.8M $292.0M $184.6M $122.5M $106.0M $120.5M $77.2M
Liabilities
Accounts Payable $46.7M $41.1M $19.0M $9.9M $4.2M $3.9M $2.8M —
Total Current Liabilities $138.9M $102.4M $66.9M $40.6M $32.1M $19.5M $14.7M $15.1M
Long-Term Debt — — — $4.6M $6.8M $7.0M — —
Total Liabilities $484.7M $119.0M $70.8M $44.4M $38.4M $29.0M $16.0M $16.2M
Stockholders' Equity
Retained Earnings $-671.8M $-621.0M $-555.4M $-497.8M $-475.4M $-445.6M $-391.1M $-346.4M
Total Stockholders' Equity $419.4M $283.8M $221.2M $140.2M $84.1M $77.0M $104.5M $61.0M
← Newer Page 2 of 2 Older →